Fundraising FoxResalis Therapeutics
Turin, IT · 4 known investors
Find your way into Resalis Therapeutics
Sign up to see every warm intro you have to Resalis Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Resalis Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Resalis Therapeutics develops antisense oligonucleotide therapies targeting microRNA pathways for metabolic disorders. The company is advancing RES-010, a treatment candidate for obesity, fatty liver disease, and related metabolic disorders.
Founders & leadership
RP
Riccardo PanellaChief Scientific Officer & Co-FounderRiccardo Panella is an Associate Professor at the Center for RNA Medicine at Aalborg University's Copenhagen campus and Chief Scientific Officer and co-founder of Resalis Therapeutics, which develops antisense oligonucleotide therapies targeting microRNA pathways for metabolic disorders.
Investors · 4
Claris Ventureslisted by Claris VenturesTorino
How we know: Claris Ventures's portfolio page · the VCSheet dataset · Not right? Tell us
Sunstone CapitalreportedFrederiksberg
How we know: the VCSheet dataset · Not right? Tell us
Also in the syndicate · 1
Sunstone Life Science Ventureslead
Funding
SEC filings, press & company announcements- Undisclosed amountSeries AJan 2024
Sunstone Life Science Ventures (lead)
Source ↗ - Undisclosed amountSeed FinancingFeb 2023Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Resalis Therapeutics do?
- Resalis Therapeutics develops antisense oligonucleotide therapies targeting microRNA pathways for metabolic disorders. The company is advancing RES-010, a treatment candidate for obesity, fatty liver disease, and related metabolic disorders.
- Who founded Resalis Therapeutics?
- Resalis Therapeutics was founded by Riccardo Panella, Sakari Kauppinen.
- Who are Resalis Therapeutics's investors?
- Resalis Therapeutics's investors include Claris Ventures, Italian Angels for Growth, Sunstone Capital.
- Where is Resalis Therapeutics headquartered?
- Resalis Therapeutics is headquartered in Turin, IT.